vimarsana.com

Latest Breaking News On - Emerald advisers - Page 4 : vimarsana.com

ACADIA Pharmaceuticals (ACAD) Market Perform Rating Reaffirmed at Oppenheimer

Oppenheimer restated their market perform rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report released on Monday, Benzinga reports. The brokerage currently has a $19.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on ACAD. Mizuho cut shares of ACADIA Pharmaceuticals from […]

Wedbush Reiterates Outperform Rating for Tenable (NASDAQ:TENB)

Wedbush reiterated their outperform rating on shares of Tenable (NASDAQ:TENB – Free Report) in a research report released on Thursday morning, Benzinga reports. Wedbush currently has a $65.00 target price on the stock. A number of other brokerages have also commented on TENB. Stephens lifted their price objective on Tenable from $60.00 to $62.00 and […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.